Multimodal nanoparticle imaging agents: design and applications

Abstract

Molecular imaging, where the location of molecules or nanoscale constructs can be tracked in the body to report on disease or biochemical processes, is rapidly expanding to include combined modality or multimodal imaging. No single imaging technique can offer the optimum combination of properties (e.g. resolution, sensitivity, cost, availability). The rapid technological advances in hardware to scan patients, and software to process and fuse images, are pushing the boundaries of novel medical imaging approaches, and hand-in-hand with this is the requirement for advanced and specific multimodal imaging agents. These agents can be detected using a selection from radioisotope, magnetic resonance and optical imaging, among others. Nanoparticles offer great scope in this area as they lend themselves, via facile modification procedures, to act as multifunctional constructs. They have relevance as therapeutics and drug delivery agents that can be tracked by molecular imaging techniques with the particular development of applications in optically guided surgery and as radiosensitizers. There has been a huge amount of research work to produce nanoconstructs for imaging, and the parameters for successful clinical translation and validation of therapeutic applications are now becoming much better understood. It is an exciting time of progress for these agents as their potential is closer to being realized with translation into the clinic. The coming 5-10 years will be critical, as we will see if the predicted improvement in clinical outcomes becomes a reality. Some of the latest advances in combination modality agents are selected and the progression pathway to clinical trials analysed.This article is part of the themed issue 'Challenges for chemistry in molecular imaging'.

Engineered Cell‐Derived Microparticles Bi2Se3/DOX@MPs for Imaging Guided Synergistic Photothermal/Low‐Dose Chemotherapy of Cancer

“…[62] As an emerging imaging modality with high sensitivity and depth imaging, PA imaging has been broadly proposed in cancer diagnosis and therapy. [62] As an emerging imaging modality with high sensitivity and depth imaging, PA imaging has been broadly proposed in cancer diagnosis and therapy.…”

Fluorinated MRI Contrast Agents and Their Versatile Applications in the Biomedical Field

“…Multimodal imaging [6], [21]- [25] is a relatively new technique able to provide more accurate diagnosis thanks to the combination of the different imaging techniques strengths meanwhile excluding their weaknesses. It is then possible to associate a poor spatial resolution technique such as SPECT or OI with a high spatial resolution but less sensitive one like MRI or CT scan.…”

Iodinated Metallacrowns: Toward Combined Bimodal Near‐Infrared and X‐Ray Contrast Imaging Agents

“…Multimodal imaging is attractivet oa chievet his specific goal by combining different imagingm odalities to obtainc omplementary information at the anatomical, functional and molecular levels. [1][2][3][4][5] The key requirementi st he availability of common probes able to operate in different imaging modalities. Among numerous imaging modalities, X-ray computedt omography( XCT) is an ideal anatomical imaging technique that allowst he detailedv isualization of organs and their contents.…”